已收录 268921 条政策

政策提纲

A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer

[摘要] Lessons Learned

[发布日期] [发布机构]

[效力级别] [学科分类] 肿瘤学

[关键词] [时效性]

浏览次数：2